DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION?

DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION?

Show other versions (1)

<p>Concept of deterioration of myocardial contractile function under long-term intake of antiarrhythmic drugs may be regarded as one of the myths of modern cardiology. Multiple references to negative influence of majority of antiarrhythmic drugs on myocardial inotropic function are speculative...

Full description

Bibliographic Details
Main Authors:	V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	фибрилляция предсердий сократительная функция сердца выбор тактики лечения ФП аритмогенное ремоделирование
Online Access:	http://www.rpcardio.ru/jour/article/view/252

Similar Items

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

Comparative evaluation of markers of inflammation and fibrosis in patients with various clinical forms of atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-12-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

HEART AND AGE (PART II): CLINICAL MANIFESTATIONS OF AGEING
by: D. U. Akasheva, et al.
Published: (2013-08-01)

SOME EARLY PREDICTORS OF A RECURRENCE OF FIBRILLATION OF AURICLES IN PATIENTS WHO HAVE UNDERGONE RFA OPERATION
by: M. V. Mostovnek, et al.
Published: (2018-03-01)

COMPARISON OF THE VALUE OF INFLAMMATION MARKERS AND HEART REMODELING PARAMETERS IN PATIENTS WITH DISTINCT TYPES OF ATRIAL FIBRILLATION
by: L. G. Azarapetyan, et al.
Published: (2015-06-01)

Профилактика инсульта у пациентов с фибрилляцией предсердий в практике врача-кардиолога и терапевта
by: Editorial Article
Published: (2014-12-01)

Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation
by: A. A. Safiullina, et al.
Published: (2022-02-01)

Atrial fibrillation after heart transplantation
by: M. Kh. Lepshokova, et al.
Published: (2018-03-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
by: V. I. Podzolkov, et al.
Published: (2018-08-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

Characteristics of cardiac contractile function changes in combined model of experimental arterial hypertension and acute coronary insufficiency after treatment with calcium channel blockers
by: K Y Kasem, et al.
Published: (2009-12-01)

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

Clinical and pathogenetic characteristics and management of patients with atrial fibrillation in a cardiology department at the present time
by: V. K. Kurashin, et al.
Published: (2020-07-01)

Патогенетические механизмы фибрилляции предсердий и формирования предсердного фиброза = Pathogenic mechanisms of atrial fibrillation and atrial fibrosis formation
by: A. I. Gozhenko, et al.
Published: (2016-10-01)

Changes in local left and right ventricular myocardial contractility in patients with recurrent atrial fibrillation
by: I. G. Fomina, et al.
Published: (2006-04-01)

Does the type of ablation device influence on the results of the treatment of atrial fibrillation in open heart surgery?
by: А. В. Богачев-прокофьев, et al.
Published: (2015-10-01)

Structural and functional heart model and its hidden kinetic properties in patients with induced atrial fibrillation
by: A. V. Chapurnykh, et al.
Published: (2005-06-01)

Recurrent atrial fibrillation predictors in patients with arterial hypertension: circadian heart rate variability analysis
by: D. V. Dedov, et al.
Published: (1970-01-01)

THE COMPARISON OF ARRHYTHMOGENICITY OF DIFFERENT SURGICAL APPROACHES TO ATRIAL FIBRILLATION IN PATIENTS WITH CORONARY HEART DISEASE
by: A. M. Chernyavsky, et al.
Published: (2014-04-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

ВЛИЯНИЕ АНТАГОНИСТОВ АЛЬДОСТЕРОНА НА ПАРАМЕТРЫ ЭЛЕКТРОКАРДИОГРАММЫ ВЫСОКОГО РАЗРЕШЕНИЯ У ПАЦИЕНТОВ С ПАРОКСИЗМАЛЬНОЙ ФОРМОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
by: Н. Т. Ватутин, et al.
Published: (2015-08-01)

Role of miRNA in the development of atrial fibrillation in patients with valvular heart disease
by: I. V. Abdulyanov, et al.
Published: (2020-11-01)

Механизмы, клиническая значимость и взаимоотношение тканевого фиброза и фибрилляции предсердий = Mechanisms, clinical significance and relationship of tissue fibrosis and atrial fibrillation = Механізми, клінічна значущість та взаємовідношення тканинного фіброзу і фібриляції передсердь
by: A. I. Gozhenko, et al.
Published: (2017-02-01)

Механизмы, клиническая значимость и взаимоотношение тканевого фиброза и фибрилляции предсердий = Mechanisms, clinical significance and relationship of tissue fibrosis and atrial fibrillation = Механізми, клінічна значущість та взаємовідношення тканинного фіброзу і фібриляції передсердь
by: A. I. Gozhenko, et al.
Published: (2017-02-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease
by: O. A. Rubanenko
Published: (2015-11-01)

The role of obesity in the development of atrial fibrillation: current problem status
by: V. I. Podzolkov, et al.
Published: (2019-09-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

Role of epicardial adipose tissue in the development of atrial fibrillation in hypertensive patients
by: V. I. Podzolkov, et al.
Published: (2020-12-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

ATRIAL FIBRILLATION AND ATHEROSCLEROSIS OF MAIN ARTERIES: IS THERE ANY CORRELATION?
by: O. A. Germanova
Published: (2020-11-01)

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation
by: E M Esedov, et al.
Published: (2014-12-01)

Патогенетические механизмы фибрилляции предсердий и формирования предсердного фиброза = Pathogenic mechanisms of atrial fibrillation and atrial fibrosis formation
by: A. I. Gozhenko, et al.
Published: (2016-10-01)

DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION?
by: V. I. Podzolkov, et al.
Published: (2015-09-01)